The Babraham Institute, a biotech research unit of Cambridge University, has announced the creation of a new commercialisation vehicle backed by a £44m ($67m) government grant.
Babraham Commercialisation Services (BCS) will support the knowledge exchange and commercialisation activities of the institute, already home to around 45 biomedical companies at its research campus. The campus is also home to Cancer Research UK’s commercialisation unit.
The institute is using the £44m UK Government grant, awarded by the Biotechnology and Biological…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?